Cargando…
Cranberry Polyphenols in Esophageal Cancer Inhibition: New Insights
Esophageal adenocarcinoma (EAC) is a cancer characterized by rapidly rising incidence and poor survival, resulting in the need for new prevention and treatment options. We utilized two cranberry polyphenol extracts, one proanthocyanidin enriched (C-PAC) and a combination of anthocyanins, flavonoids,...
Autores principales: | Weh, Katherine M., Zhang, Yun, Howard, Connor L., Howell, Amy B., Clarke, Jennifer L., Kresty, Laura A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912450/ https://www.ncbi.nlm.nih.gov/pubmed/35267943 http://dx.doi.org/10.3390/nu14050969 |
Ejemplares similares
-
Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents
por: Weh, Katherine M., et al.
Publicado: (2016) -
Cranberry proanthocyanidins modulate reactive oxygen species in Barrett’s and esophageal adenocarcinoma cell lines
por: Weh, Katherine M., et al.
Publicado: (2016) -
Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation
por: Kresty, Laura A., et al.
Publicado: (2015) -
MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention
por: Kresty, Laura A., et al.
Publicado: (2011) -
Cranberry Proanthocyanidins Mediate Growth Arrest of Lung Cancer Cells through Modulation of Gene Expression and Rapid Induction of Apoptosis
por: Kresty, Laura A., et al.
Publicado: (2011)